Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Synchron›
Products & Services
AddedApr 29, 2026
UpdatedMay 29, 2026
ST

Synchron› offers Stentrode

Product
Currently Offered

Endovascular brain-computer interface implanted via the jugular vein, decoding motor cortex signals without open-skull surgery.

Loading
Overview

The Stentrode system combines three hardware components: an endovascular electrode array seated in a cortical blood vessel to detect neural firing patterns; an Internal Receiver Transmitter (IRT) implanted in the chest; and an external Signal Processing Unit (SPU) that decodes motor intent and routes commands to a paired smartphone or tablet. Because the array is delivered through the jugular vein, the procedure resembles stent placement rather than conventional neurosurgery, eliminating the need for a craniotomy.

The system is designed for people living with tetraplegia who retain motor intent but have lost the physical pathways to act on it. By translating cortical signals into digital inputs, it enables users to schedule appointments, send messages, and conduct online transactions via thought-driven touchscreen control; the technology carries investigational status under U.S. federal law and is being evaluated in ongoing clinical trials.

Stentrode - Direct Competitors

  • Blackrock Neurotech

    Blackrock Neurotech logo

    MoveAgain BCI, NeuroPort Array

    blackrockneurotech.com

AttributeStentrodeMoveAgain BCI, NeuroPort Array
ProviderSynchronsynchron.com$130M raisedBlackrock Neurotechblackrockneurotech.com$220M raised
Founded20162008
Sells ToEnterpriseEnterprise, Government
Pricing ModelSoftwareRecurring, Transactional
OwnershipEquity, Venture CapitalPrivate
Stentrode

Provider Synchronsynchron.com$130M raised

Founded 2016

Sells To Enterprise

Pricing Model Software

Ownership Equity, Venture Capital

MoveAgain BCI, NeuroPort Array

Provider Blackrock Neurotechblackrockneurotech.com$220M raised

Founded 2008

Sells To Enterprise, Government

Pricing Model Recurring, Transactional

Ownership Private

Stentrode - Similar Products & Services

  • Neuralink Telepathy logo

    Neuralink Telepathy

    neuralink.com